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Abstract
Long-term potentiation (LTP) in the anterior cingulate cortex (ACC) is believed to be critical for
higher brain functions including emotion, learning, memory and chronic pain. N-methyl-D-aspartate
(NMDA) receptor-dependent LTP is well studied and is thought to be important for learning and
memory in mammalian brains. As the downstream target of NMDA receptors, the extracellular
signal-regulated kinase (ERK) in the mitogen-activated protein kinase (MAPK) cascade has been
extensively studied for its involvement in synaptic plasticity, learning and memory in hippocampus.
By contrast, the role of ERK in cingulate LTP has not been investigated. In this study, we examined
whether LTP in ACC requires the activation of ERK. We found that P42/P44 MAPK inhibitors,
PD98059 and U0126, suppressed the induction of cingulate LTP that was induced by presynaptic
stimulation with postsynaptic depolarization (the pairing protocol). We also showed that cingulate
LTP induced by two other different protocols was also blocked by PD98059. Moreover, we found
that these two inhibitors had no effect on the maintenance of cingulate LTP. Inhibitors of c-Jun N-
terminal kinase (JNK) and p38, other members of MAPK family, SP600125 and SB203850,
suppressed the induction of cingulate LTP generated by the pairing protocol. Thus, our study
suggests that the MAPK signaling pathway is involved in the induction of cingulate LTP and plays a
critical role in physiological conditions.
Introduction
The prefrontal cortex, including the anterior cingulate cor-
tex (ACC) is believed to play important roles in emotion,
learning, memory and persistent pain in the adult brain
[1-7]. Long-term potentiation (LTP), known to be
involved in learning and memory, is a key synaptic mech-
anism for cortical synaptic plasticity [8]. Recent studies
demonstrate that LTP can be induced in the cingulate
slices [3,9,10]. However, several recent studies showed
that molecular signaling pathways involved in the synap-
tic potentiation in the ACC differ from those in the hip-
pocampus. For example, both N-methyl-D-aspartate
(NMDA) receptor subunit 2A and 2B (NR2A and NR2B)
contribute to cingulate LTP [3], while NR2A is preferen-
tially contributing to hippocampal LTP [11,12]. For cal-
cium-related signaling messengers, calcium-calmodulin
(CaM) dependent adenylyl cyclase (AC) type 1 is critical
for synaptic LTP in the ACC [9], while AC1 deletion alone
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the downstream targets of calcium-stimulated cAMP-
dependent signaling pathways underlying LTP in the ACC
synapses have been far less investigated compared to hip-
pocampal synapses.
As the downstream target of cAMP signaling pathways,
mitogen-activated protein kinase (MAPK) is well charac-
terized in the hippocampus [14,15]. The MAPK is a family
of serine/threonine protein kinases that transduce extra-
cellular signals from cell surface receptors to the cell
nucleus [16,17]. The MAPK cascade includes extracellular
signal-regulated (ERK), p38, c-Jun N-terminal kinase
(JNK), and ERK5 [17]. The activation of ERK is coupled to
stimulation of cell surface receptors via several different
upstream signaling pathways, and plays critical roles in
the regulation of gene expression and cell proliferation
[18]. In neurons, the ERK signaling pathway is activated
by synaptic activity such as membrane depolarization, cal-
cium influx and neurotrophins [19-21]. Furthermore, the
ERK signaling pathway might regulate synaptic targets to
control important functions such as synaptic plasticity,
learning and memory in the adult brain [15,22,23]. How-
ever, the role of ERK signaling pathway in the cingulate
synaptic plasticity has not been investigated.
In the present study, we performed whole-cell patch-
clamp recordings from cingulate neurons of adult mice
and investigated the role of MAPK in the cingulate synap-
tic potentiation. Here, we show that LTP induced by three
different induction protocols were completely blocked by
the MAPK/ERK kinase (MEK) inhibitor applied postsyn-
aptically. Furthermore, we found that the MEK inhibitors
did not affect the maintenance of cingulate LTP. Inhibi-
tors of c-Jun N-terminal kinase (JNK) and p38 also sup-
pressed the induction of cingulate LTP generated by the
pairing protocol. These results suggest that the activation
of MAPK including ERK, JNK and p38, is critical for the
induction of LTP in the ACC.
Results
Postsynaptic injection of MAPK inhibitors blocks the 
cingulate LTP
We performed conventional whole-cell patch-clamp
recordings from visually identified pyramidal neurons in
the layer II/III of cingulate slices. Fast EPSCs were
obtained by delivering focal electrical stimulation to the
layer V. First, we identified pyramidal neurons based on
the pyramidal shape of their somata by loading Lucifer
yellow into the intracellular solution [3]. We also con-
firmed that the recordings were performed from cortical
pyramidal cells by injecting depolarizing currents into the
neuron. Injection of depolarizing currents into neurons
induced repetitive action potentials with significant firing
frequency adaptation [3]. Next, we carried out experi-
ments to determine if the pairing of synaptic activity with
postsynaptic depolarization (or called the pairing proto-
col) may induce long-term potentiation (LTP) of synaptic
responses in the ACC. We induced LTP by pairing 80 pre-
synaptic pulses at 2 Hz with postsynaptic depolarization
(holding at + 30 mV) [3,24]. LTP was induced with the
pairing protocol within 12 minutes after establishing the
whole-cell configuration to avoid washout of intracellular
contents that are critical for the establishment of synaptic
plasticity [3]. Indeed, the pairing protocol produced a sig-
nificant, long-lasting potentiation of synaptic responses
(161.9 ± 11.7%, n = 13, P < 0.05 compared with baseline
response, Fig. 1B, D).
In our previous study, we have shown that the expression
of LTP in the ACC depends on a postsynaptic mechanism
[3]. Therefore, we examined the effects of MAPK inhibi-
tors on cingulate LTP by postsynaptic injection. We tested
whether LTP induced by the pairing protocol is prevented
by postsynaptic application of a MAPK inhibitor,
PD98059 [25] (Fig. 1C, D). Postsynaptic injection of
PD98059 (5 μM), in the intracellular solution had no
effect on cingulate LTP induced by the pairing protocol (5
μM; 152.3 ± 16.8%, n = 8, P < 0.05 compared with base-
line response, Fig. 1D). However, PD98059 at higher con-
centrations (15 and 50 μM) completely blocked the
induction of cingulate LTP (15 μM; 114.8 ± 17.4%, n = 6,
P > 0.05 compared with baseline response, 50 μM: 107.3
± 7.4%, n = 10, P > 0.05 compared with baseline response,
Fig. 1B, D). It has been reported that an alteration in
AMPA receptor channel kinetics could underlie the
expression of LTP [26]. Then, we analyzed the rise and
decay times before and after the induction of LTP to exam-
ine whether LTP induced by the pairing protocol involves
a change in the kinetics of the EPSCs. The rise and decay
times of EPSCs showed no difference before and after the
application of the pairing protocol (data not shown).
Those of EPSCs were also not affected by the intracellular
perfusion of PD98059 (50 μM) (data not shown).
We also used another MEK inhibitor U0126 (50 μM) in
the intracellular solution [27]. Postsynaptic application of
U0126 completely blocked the induction of LTP gener-
ated by the pairing protocol (U0126; 104.4 ± 8.1%, n = 7,
P > 0.05 compared with baseline response, Fig. 1E, F).
Then we tested the effects of JNK or p38 inhibitor on the
induction of cingulate LTP, because the MAPK signaling
pathways include extracellular signal-regulated (ERK), c-
Jun N-terminal kinase (JNK), p38 and ERK5 [17]. Similar
to MEK inhibitors, a JNK inhibitor, SP600125 (10 μM)
[28] or a p38 inhibitor, SB203580 (10 μM) [29] signifi-
cantly suppressed the induction of cingulate LTP
(SP600125: 111.3 ± 17.1%, n = 6, P > 0.05 compared with
baseline response; SB203580: 114.0 ± 16.6%, n = 6, P >
0.05 compared with baseline response, Fig. 1F). SincePage 2 of 15
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Postsynaptic inhibition of PD98059 prevents the induction of cingulate LTPFigure 1
Postsynaptic inhibition of PD98059 prevents the induction of cingulate LTP. A: A scheme illustrating the LTP induction proto-
col consisting of pairing 80 presynaptic pulses at 2 Hz with postsynaptic depolarization (holding at + 30 mV). B: LTP is induced by the pair-
ing protocol in cingulate pyramidal neurons (n = 13). C: The MEK inhibitor, PD98059 (50 μM, n = 10) in the intracellular solution 
completely blocks LTP induction. Traces show averages of six EPSCs at baseline response (pre) and 30 min (post) after the pairing proto-
col (arrow). The dashed line indicates the mean basal synaptic response. D: Summary of the effects of PD98059 at different concentra-
tions on LTP induced by the pairing protocol (PD98059; 5 μM, n = 8; 15 μM, n = 6, 50 μM, n = 10). * P < 0.05 compared to baseline 
response. E: The MEK inhibitor U0126 (50 μM) in the intracellular solution completely blocks LTP induction. Traces show averages of six 
EPSCs at baseline response (pre) and 30 min (post) after the pairing protocol (arrow). The dashed line indicates the mean basal synaptic 
response. F: Summary of the effects of MAPK inhibitors on LTP induced by the pairing protocol (U0126; n = 7, SP600125; n = 6, 
SB203850; n = 6). * P < 0.05 compared to baseline response.
Molecular Pain 2007, 3:36 http://www.molecularpain.com/content/3/1/36PD98059 and U0126 have been reported to also inhibit
MEK5, the upstream regulator of ERK5 [30], these results
suggest that the activation of all MAPK signaling pathways
is required for the induction of cingulate LTP. However,
we can not completely rule out possible non-selective
effects of pharmacological inhibitors.
Inhibition is independent of the induction protocols
To test whether the activation of ERK may depend on a
specific LTP induction paradigm, we decided to test the
role of PD98059 in cingulate LTP using two other differ-
ent induction protocols. First, we tested a protocol of
coincidence of postsynaptic action potentials (APs) and
unitary EPSPs (or called EPSP-AP) to induce LTP [31,32]
(Fig. 2A). This protocol is useful to test synaptic modifica-
tions, since precise spike timing may be used in the infor-
mation processing in the neocortex [33]. Coincidence
between EPSPs and backpropagating APs leads to the
induction of LTP or LTD, depending on the timing of
EPSPs and APs. Repetitive postsynaptic spiking within a
LTP induced by EPSP-AP protocol is blocked by PD98059Figure 2
LTP induced by EPSP-AP protocol is blocked by PD98059. A: A scheme illustrating the LTP induction protocol consisting of 3 
EPSPs and 3 APs (10 ms ahead) at 30 Hz, which are repeated 15 times with the interval of 5 s. B: LTP is induced by the EPSP-AP protocol. 
This protocol induces significant LTP in adult ACC neurons (n = 8). C: LTP is blocked by addition of PD98059 in the intracellular solution. 
Traces show averages of six EPSCs at baseline response (pre) and 30 min (post) after the EPSP-AP protocol (arrow). The dashed line indi-
cates the mean basal synaptic response. D: Summary of the effects of PD98059 (50 μM, n = 7) and U0126 (50 μM, n = 6) on LTP induced 
by the EPSP-AP protocol. * P < 0.05 compared to baseline response.Page 4 of 15
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resulted in LTP [31]. This protocol induced a significant,
long-lasting potentiation of synaptic responses (140.6 ±
9.0%, n = 8, P < 0.05 compared with baseline response;
Fig. 2B, D). The potentiation was completely blocked by
50 μM PD98059 or 50 μM U0126 in the intracellular
solution (PD98059: 104.8 ± 5.1%, n = 7, P > 0.05 com-
pared with baseline response; U0126: 92.6 ± 9.6%, n = 6,
P > 0.05 compared with baseline response) (Fig. 2C, D).
Next, we induced LTP using theta-burst stimulation (TBS)
[3,34] (Fig. 3A). This paradigm is thought to be physiolog-
ical, since the synchronized firing patterns at similar fre-
quencies are observed during learning in the
hippocampus [35]. We found that TBS induced significant
LTP in the cingulate neurons (151.8 ± 12.7%; n = 8, P <
0.05 compared with baseline response) (Fig. 3B). The
induction of LTP was also blocked by 50 μM PD98059 in
the intracellular solution (106.1 ± 2.6%; n = 6, P > 0.05
compared with baseline response) (Fig. 3C, D). Taken
LTP induced by TBS protocol is blocked by PD98059Figure 3
LTP induced by TBS protocol is blocked by PD98059. A: A scheme illustrating the LTP induction protocol consisting of 5 trains of 
burst with 4 pulses at 100 Hz, 200 ms interval, which are repeated 4 times with the interval of 10 s. B: LTP is induced by the TBS proto-
col. The TBS protocol induced significant LTP in the ACC of adult mice (n = 8). C: LTP is blocked by addition of PD98059 (50 μM) in the 
intracellular solution. Traces show averages of six EPSCs at baseline response (pre) and 30 min (post) after the TBS protocol (arrow). 
The dashed line indicates the mean basal synaptic response. D: Summary of the effects of PD98059 (50 μM, n = 6) on LTP induced by the 
TBS protocol. * P < 0.05 compared to baseline.Page 5 of 15
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in LTP induction is not dependent on specific induction
paradigms.
LTP can be induced in the absence of picrotoxin
Previous studies indicate that LTP of glutamatergic syn-
apses in the lateral amygdala is controlled by GABAA
receptor-mediated inhibition (Shumyatsky et al, 2002;
Bissiere et al, 2003). Thus, we examined whether the pair-
ing or EPSP-AP protocol induces LTP in ACC synapses in
the absence of picrotoxin. We found that LTP in the ACC
was induced by the pairing protocol, even in the absence
of picrotoxin (127.8 ± 10.0%, n = 8, P < 0.05 compared
with baseline response, Fig. 4A, B). However, LTP induced
by the pairing protocol in the absence of picrotoxin was
significantly smaller than that in the presence of picro-
toxin (see Fig. 1B, D) (P < 0.05, Fig. 4B). Postsynaptic
application of PD98059 (50 μM) in the absence of picro-
LTP induced by pairing and EPSP-AP protocols in the absence and presence of picrotoxinFigure 4
LTP induced by pairing and EPSP-AP protocols in the absence and presence of picrotoxin. A, B: In the absence of picrotoxin 
(No picrotoxin), LTP induced by the pairing protocol (n = 8) is significantly reduced compared to that in the presence of picrotoxin 
(Picrotoxin; n = 13, see Fig. 1B, D). PD98059 (50 μM, n = 6) blocks the pairing-induced LTP in the absence of picrotoxin (No picrotoxin 
+ PD98059). * P < 0.05 compared with EPSC amplitude (%) in the absence of picrotoxin (No picrotoxin). C, D: LTP induced by the EPSP-
AP protocol shows no difference between in the absence (No picrotoxin, n = 9) and presence (Picrotoxin, n = 8, see Fig. 2B, D) of picro-
toxin.Page 6 of 15
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6, P > 0.05 compared with baseline response, Fig. 4B).
Next, we examined the effect of picrotoxin on LTP
induced by the EPSP-AP protocol. Our results showed that
LTP induced by the EPSP-AP protocol showed no differ-
ence between in the absence (137.6 ± 11.5%, n = 9, P <
0.05 compared with baseline response) and presence
(140.6 ± 9.0%, see Fig. 2B, D) of picrotoxin (Fig. 4C, D).
These results indicate that different LTP induction proto-
cols would cause different inhibitory actions in the ACC
synapses.
ERK inhibitors do not affect AMPA receptor-mediated 
baseline EPSCs
In the following series of experiments, we used ERK inhib-
itors by bath application to test whether these drugs affect
basal synaptic transmission, because it is reported that
activation of presynaptic MAPK may enhance synaptic
vesicle recycling and regulate short-time presynaptic plas-
ticity in cultured hippocampal neurons [36].
First, we examined the effects of these inhibitors on AMPA
receptor-mediated baseline EPSCs in cingulate slices. To
record AMPA receptor-mediated EPSCs, we added AP-5
(50 μM) in the recording solution. Bath application of
PD98059 or U0126 did not affect the AMPA receptor-
mediated baseline EPSCs (PD98059 (100 μM): last 5 min
of application, 101.5 ± 3.8 % of baseline response, n = 10,
P > 0.05, Fig. 5A; U0126 (100 μM): last 5 min of applica-
tion, 102.4 ± 4.6 % of baseline response, n = 6, P > 0.05,
Fig. 5B). The rise and decay times of AMPA receptor-medi-
ated EPSCs were not significantly altered during the
recordings in the presence of PD98059 or U0126 (Fig. 5A,
B).
NMDA receptor-mediated baseline EPSCs
NMDA receptors are critical for the induction of cingulate
LTP [3]. To test the possibility that MEK inhibitors affect
the induction of LTP by inhibiting NMDA receptor-medi-
ated currents, we examined the effects of the MEK inhibi-
tors on synaptically induced NMDA receptor-mediated
baseline EPSCs. We applied the MEK inhibitors in the
extracellular solution after recording the baseline current
responses. As we have shown in Fig. 6, NMDA receptor-
mediated baseline EPSCs had not been changed by bath
application of PD98059 or U0126 (PD98059 (100 μM):
last 5 min of application, 102.1 ± 3.2 % of baseline
response, n = 7, P > 0.05, Fig. 6A; U0126 (100 μM): last 5
min of application, 101.1 ± 5.2 % of baseline response, n
= 7, p > 0.05, Fig. 6B). We further analyzed whether the
MEK inhibitors affect the kinetics of NMDA receptor-
mediated EPSCs. The rise and decay times of NMDA
receptor-mediated EPSCs were not significantly altered
during the recording in the presence of PD98059 or
U0126 (Fig. 6A, B). These results suggest that PD98059
and U0126 do not inhibit LTP by simply inhibiting
NMDA receptor function.
Paired-pulse facilitation
We also examined the effect of PD98059 and U0126 on
paired-pulse facilitation (PPF), a simple form of synaptic
plasticity. Bath application of PD98059 (100 μM) or
U0126 (100 μM), did not affect PPF at all time points
(control, n = 13, PD98059, n = 7: U0126, n = 6) (Fig. 7).
These results suggest that the MEK inhibitors had no effect
on basal synaptic transmissions in ACC synapses.
The maintenance of LTPTo examine the effect of PD98059
and U0126 on the maintenance of LTP, PD98059 (100
μM) or U0126 (100 μM) was bath applied 10 min after
the pairing protocol. In contrast to the application before
the induction, we found no significant effect on the main-
tenance of LTP during the 20 min treatment with
PD98059 or U0126 (PD98059, 156.5 ± 9.0 % at 30 min
after the pairing protocol, 20 min after PD98059 treat-
ment, n = 7, P < 0.05 compared with baseline response,
Fig. 8A; U0126, 152.9 ± 5.7 % at 30 min after the pairing
protocol, 20 min after U0126 treatment, n = 5, P < 0.05
compared with baseline response, Fig. 8B). These results
suggest that the ERK inhibitors have no effect on the
maintenance of cingulate LTP.
Discussion
In this study, we demonstrated that ERK activation is
required for the induction of LTP in the ACC and that the
MEK inhibitors did not affect the maintenance phase of
cingulate LTP. Furthermore, we showed that inhibitors of
other members of MAPK family, such as JNK and p38,
also blocked the induction of cingulate LTP generated by
the pairing protocol. Thus, ERK/MAPK activation is essen-
tial for triggering long-term synaptic changes in the ACC,
which plays critical roles in physiological and pathologi-
cal conditions.
The ERK activation in synaptic plasticity
The role of ERK in synaptic plasticity has been shown in
several organisms including invertebrates and vertebrates.
The ERK signaling pathway has been shown to be required
for long-term facilitation of the sensory to motor synapse
in the invertebrates, Aplysia [37]. On the other hand, the
ERK signaling pathway has also been extensively studied
in vertebrates, especially in mammalian brains (Table 1).
The first evidence about the role of ERK activation in syn-
aptic plasticity was shown in the CA1 region of the hip-
pocampus [23], where NMDA-dependent LTP was
blocked by a MEK inhibitor, PD98059. Thereafter, this
phenomenon has been replicated by other studies
[22,38,39]. The ERK activation is involved in NMDA
receptor-independent LTP as well [40]. The involvementPage 7 of 15
(page number not for citation purposes)
Molecular Pain 2007, 3:36 http://www.molecularpain.com/content/3/1/36
Page 8 of 15
(page number not for citation purposes)
MEK inhibitors do not affect the AMPA receptor-mediated EPSCsFigure 5
MEK inhibitors do not affect the AMPA receptor-mediated EPSCs. A, B: Bath application of PD98059 (50 μM, n = 10) or U0126 
(50 μM, n = 6) does not affect the AMPA-receptor-mediated EPSCs. The insets show averages of six EPSCs before (Control; open) and 
after (PD98059 or U0126; solid) application of PD98059 or U0126. The dashed line indicates the mean basal synaptic response. Decay 
time versus rise time for AMPA receptor-mediated EPSCs before (Control; open) and after (PD98059 or U0126; solid) application of 
PD98059 or U0126.
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MEK inhibitors do not affect the NMDA receptor-mediated EPSCsFigure 6
MEK inhibitors do not affect the NMDA receptor-mediated EPSCs. A, B: Bath application of PD98059 (100 μM, n = 7) or 
U0126 (100 μM, n = 7) does not affect NMDA receptor-mediated EPSCs. The insets show averages of six NMDA receptor-mediated 
EPSCs before (Control; open) and after (PD98059 or U0126; solid) application of PD98059 or U0126. Decay time versus the rise time 
for NMDA receptor-mediated EPSCs before (Control; open) and after (PD98059 or U0126; solid) application of PD98059 or U0126.
Molecular Pain 2007, 3:36 http://www.molecularpain.com/content/3/1/36of ERK in synaptic plasticity has also been reported in a
number of other brain areas. In the dentate gyrus, the ERK
activity is required for multiple forms of synaptic plastic-
ity including NMDA-dependent and NMDA-independent
LTP [41], and such activity is necessary for in vivo LTP
[25,42,43]. Furthermore, the ERK activation is essential
for both memory consolidation of Pavlovian fear condi-
tioning and synaptic plasticity in the lateral amygdala
[44], which might be related to synthesis of new protein
and mRNA [45]. In the cerebral cortex, the functional sig-
nificance of the ERK signaling in synaptic plasticity has
been well investigated. For instance, the ERK activation is
involved in both synaptic plasticity and taste learning in
the insular cortex [46]. Additionally, it has been reported
that the blockade of ERK activation prevented LTP in the
developing visual cortex and blocked the ocular domi-
nance shift induced by monocular deprivation [47].
Recently, we have shown that the postsynaptic inhibition
of the ERK pathway blocked LTP in superficial dorsal horn
neurons [48], suggesting that the ERK activation in the
superficial dorsal horn of the spinal cord can be patho-
physiologically related to spinal sensitization and chronic
pain after injury. Thus, the ERK signaling pathway is
essential for many forms of synaptic plasticity. The ERK
activation is also suggested to contribute to the formation
of LTD as well as LTP in the prefrontal cortex, in which the
ERK activation is required for LTD mediated by the coac-
tivation of dopamine receptors and metabotropic gluta-
mate receptors [49].
The molecular mechanism of synaptic potentiation in the 
ACC
The molecular and cellular mechanisms of synaptic
potentiation in the ACC are beginning to be elucidated by
pharmacological and genetic studies. The neuronal activ-
ity triggered by LTP-inducing stimuli increases the release
of glutamate in the cingulate synapses. The activation of
NMDA receptors including NR2A and NR2B subunits and
L-type voltage-gated calcium channels (L-VDCCs) induces
an increase in postsynaptic calcium in dendritic spines
MEK inhibitors do not affect the paired-pulse facilitationFigure 7
MEK inhibitors do not affect the paired-pulse facilitation. A: Sample traces show averages of six paired-pulse facilitation (PPF: the 
ratio of EPSC2/EPSC1) EPSCs at the 50 ms interval. B: PD98059 (100 μM, n = 7) or U0126 (100 μM, n = 6) in the extracellular solution 
has no effect on PPF.Page 10 of 15
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MEK inhibitors do not affect the maintenance phase of LTPFigure 8
MEK inhibitors do not affect the maintenance phase of LTP. A, B: PD98059 (100 μM) or U0126 (100 μM) does not affect the 
maintenance of LTP (PD98059, n = 7: U0126, n = 5). The insets show averages of six EPSCs at baseline responses and 30 min after induc-
tion of the pairing protocol (arrow). The dashed line indicates the mean basal synaptic response.
Molecular Pain 2007, 3:36 http://www.molecularpain.com/content/3/1/36[3,9]. Calcium influx via NMDA receptors and L-VDCCs
plays a key role for triggering biological processes that
lead to cingulate LTP. Postsynaptic calcium binds to cal-
modulin (CaM) and triggers various intracellular protein
kinases and phosphatases [50]. CaM target proteins, such
as Ca2+/CaM-dependent protein kinases (PKC, CaMKII
and CaMKIV), CaM-activated ACs (AC1 and 8), and the
CaM-activated phosphatase calcineurin, are known to be
important for synaptic plasticity in the hippocampus
[8,51,52]. Among them, activation of AC1 and CaMKIV
have been reported to be essential for the induction of LTP
in the ACC [4,9]. As the downstream target of AC1, cyclic-
AMP(cAMP)-dependent protein kinase (PKA) has been
well documented, which may activate MEK and ERK/
MAPK via the activation of AC1. Activated ERK/MAPK
likely has multiple targets including cAMP response ele-
ment binding protein (CREB) that is required for long-
term synaptic changes in neurons [4]. In the present study,
JNK [28] or p38 inhibitor [29] blocked the induction of
cingulate LTP generated by the pairing protocol, indicat-
ing that JNK and p38 would be involved in the induction
of cingulate LTP. By contrast, in hippocampus, it has been
reported that different MAPK cascades plays different roles
for synaptic plasticity; Ras-Erk1/2 for LTP, Rap1-p38 for
LTD, and Rap2-JNK for depotentiation [53].
LTP is typically divided into two phases such as early-
phase and late-phase LTP (E-LTP and L-LTP, respectively).
E-LTP depends on the activation of kinases and phos-
phatases, while L-LTP depends on the change of gene
expression. Considering the importance of ERK in regulat-
ing gene expression, the ERK activation may be required
for L-LTP. In previous reports, not only L-LTP but also E-
LTP were inhibited by the MEK inhibitor, PD98059
[16,38]. Thus, the ERK signaling not only regulates the
gene expression required for L-LTP, but also contributes to
activation of several kinases required for E-LTP. In the
present study, the maintenance of cingulate LTP was not
affected by PD98059, suggesting that the ERK signaling
cascade is not persistently activated during LTP in the
ACC. This phenomenon is consistent with a previous
report, in which PD98059 had no effect on the expression
of LTP in the hippocampus [23]. The molecular mecha-
nisms underlying the maintenance of LTP are not well
understood. Calcium influx into the postsynaptic mem-
brane is an essential process in the induction of LTP [54],
and this enhanced calcium levels in the postsynaptic neu-
rons activate several protein kinases including the CaM-
KII, which plays a pivotal role in the induction of LTP
[38,55,56]. Autophosphorylation of the CaMKII leads the
kinase into an autonomous mode of activity, and this
molecular switch is believed to be important for experi-
ence-dependent synaptic plasticity, learning, and memory
in the hippocampus [52,55]. Since protein kinase C
(PKC) and CaMKII have been shown to be required for
the induction, but not maintenance of hippocampal LTP
[52,55], such autonomous activation of ERK might have
contributed to the maintenance of cingulate LTP. Thus,
the MEK inhibitors would have an inhibitory effect on the
induction but not the maintenance of LTP. Taken
together, the ERK activation is an important signaling cas-
cade in triggering the synaptic potentiation in the ACC.
Physiological and pathological significance
The prefrontal cortex, including the ACC, is thought to be
important for higher brain functions in emotion, learn-
ing, memory and chronic pain [1-6,57]. Previous our
studies using AC1 and AC8 double-knockout or NR2B
overexpressed mice show that the AC1, AC8 and NR2B
receptors in the ACC contribute to the behavioral allody-
nia [4,58]. Roles for the ACC in remote contextual fear
memory [57] and spatial memory [1] have also been
reported. By contrast, another line of evidence suggests
that the ACC may play a critical role in the acquisition of
fear memory [2,3]. Indeed, fear memory has been caused
by direct stimulation of the ACC [2], and NR2B subunit in
the ACC has been demonstrated to be involved in the
induction of LTP and acquisition of contextual fear mem-
ory [3]. Although the ERK activation in the prefrontal cor-
tex has been indicated to play a critical role in long-term
memory storage [59], more studies are necessary to under-
stand the roles of ERK in the formation of contextual fear
memory and persist pain. Furthermore, it has been
reported that the ERK activation in prefrontal cortex con-
tributed to reward and aversion effects of drugs of abuse
[60] and that ERK phosphorylation in the prefrontal cor-
tex increased under chronic stress state [61]. Therefore, the
ERK activation in the ACC is necessary for not only phys-
iological but also pathological conditions. Understanding
Table 1: The role of ERK in synaptic potentiation in the 
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insight about cortical processing and memory formation
under physiological and pathological conditions.
Methods
Animals and slice preparation
The Animal Care and Use Committee of University of
Toronto approved the mouse protocols. C57BL/6 mice
(6–8 weeks old) were anesthetized with halothane, and
coronal brain slices (300 μM) containing the ACC were
prepared using our previous methods [3,10,62]. Slices
were transferred to a submerged recovery chamber with
oxygenated (95% O2 and 5% CO2) artificial cerebrospinal
fluid (ACSF) containing (in mM: 124 NaCl, 2.5 KCl, 2
CaCl2, 1 MgSO4, 25 NaHCO3, 1 NaH2PO4, 10 glucose) at
room temperature for at least 1 h.
Whole-cell patch-clamp recordings
Experiments were performed in a recording chamber on
the stage of an Axioskop 2FS microscope with infrared
DIC optics for visualization of whole-cell patch clamp
recording. Neurons of the ACC in the layer II, III and V
received afferent input from the thalamus [63]. In the
present study, excitatory postsynaptic currents (EPSCs)
were recorded from the layer II/III neurons with an Axon
200B amplifier (Molecular Devices, CA) and the stimula-
tions were delivered by a bipolar tungsten stimulating
electrode placed in the layer V of the ACC slices [3,10,62].
EPSCs were induced by repetitive stimulations at 0.02 Hz
and neurons were voltage clamped at -70 mV. The record-
ing pipettes (3–5 MΩ) were filled with solution contain-
ing (mM) 145 K-gluconate, 5 NaCl, 1 MgCl2, 0.2 EGTA,
10 HEPES, 2 Mg-ATP, and 0.1 Na3-GTP (adjusted to pH
7.2 with KOH). In the most of experiment, picrotoxin
(100 μM) was present to block GABAA receptor-mediated
inhibitory currents. In some experiment, LTP was induced
in the absence of picrotoxin. Three kinds of LTP induction
paradigms were used within 12 min after establishing the
whole-cell configuration to prevent wash out effect on
LTP induction [3]. The first protocol was pairing 80 pres-
ynaptic pulses at 2 Hz with postsynaptic depolarization at
+ 30 mV (referred to as the pairing protocol, [24]. The sec-
ond protocol was paired 3 presynaptic stimuli which
caused 3 excitatory postsynaptic potentials (EPSPs) (10
ms ahead) with 3 postsynaptic APs elicited by 0.5 nA, 10
ms current steps at 30 Hz, paired 15 times every 5s in the
current clamp mode [32]. The third protocol was theta-
burst stimulation (5 trains of burst with 4 pulses at 100
Hz, 200 ms interval; repeat 4 times with interval of 10 s)
[3]. NMDA receptor-mediated component of EPSCs was
pharmacologically isolated in ACSF containing: CNQX
(20 μM), glycine (1 μM) and picrotoxin (100 μM). The
patch electrodes contained (in mM) 102 cesium gluco-
nate, 5 TEA chloride, 3.7 NaCl, 11 BAPTA, 0.2 EGTA, 20
HEPES, 2 MgATP, 0.3 NaGTP, and 5 QX-314 chloride
(adjusted to pH 7.2 with CsOH). Neurons were voltage
clamped at -30 mV and NMDA receptor-mediated EPSCs
were evoked at 0.05 Hz. Access resistance was 15–30 MΩ
and was monitored throughout the experiment.
Pharmacological inhibitors
All chemicals and drugs including PD98059 and U0126
were obtained from Sigma (St. Louis, MO), except for QX-
314, SP600125 and SB203580 that were from Tocris
Cookson (Ellisville, MO). PD98059, U0126, SP600125
and SB203580 were dissolved in DMSO and diluted more
than 1000-fold to give a final concentration in intracellu-
lar solution or ACSF. The diluted DMSO in intracellular
solution or ACSF had no effect on synaptic transmission
and plasticity.
Data analysis and statistics
Data were collected and analyzed using pClamp 9.2 soft-
ware (Axon Instruments). Data were discarded if access
resistance changed more than 15% during an experiment.
Rise times were determined between 10 and 90% of the
peak amplitude of the evoked EPSC (eEPSCs). Decay
times were measured from the peak to 37% of peak ampli-
tude of eEPSCs. Statistical comparisons were performed
using the Student's t-test. The level of significance was set
at P < 0.05.
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